会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 32. 发明申请
    • BENZOQUINOLIZINE DERIVATIVES AND MEDICINAL COMPOSITIONS
    • 苯并喹啉衍生物和药物组合物
    • WO1997040046A1
    • 1997-10-30
    • PCT/JP1997001320
    • 1997-04-17
    • NIPPON SHINYAKU CO., LTD.YAMAMOTO, OsamuSHIROUCHI, Yoshiaki
    • NIPPON SHINYAKU CO., LTD.
    • C07D455/04
    • C07D455/06A61K31/473C07D455/04
    • Benzoquinolizine derivatives represented by general formula (1), pharmaceutically acceptable salts thereof and medicinal compositions containing the same as the active ingredients, wherein R represents hydroxy or alkoxy; R represents hydrogen, hydroxy or alkoxy; R represents alkyl optionally substituted by hydroxy, alkoxy, amino, monoalkylamino or dialkylamino; and R represents alkyl optionally substituted by hydroxy or alkoxy, aryl optionally sustituted by alkyl, halogeno, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino, monoalkylamino or dialkylamino. Because of being capable of regulating the gastro-intestinal tract motion, these compounds are efficacious in the treatment of irritable bowel syndrome.
    • 由通式(1)表示的苯并喹嗪衍生物,其药学上可接受的盐和含有与活性成分相同的药物组合物,其中R 1表示羟基或烷氧基; R 2表示氢,羟基或烷氧基; R 3表示任选被羟基,烷氧基,氨基,单烷基氨基或二烷基氨基取代的烷基; 并且R 4表示任选被羟基或烷氧基取代的烷基,任选被烷基,卤代,羟基,烷氧基,氨基,单烷基氨基或二烷基氨基,单烷基氨基或二烷基氨基取代的芳基。 由于能够调节胃肠道运动,这些化合物对肠易激综合征的治疗是有效的。
    • 34. 发明申请
    • MORANOLINE DERIVATIVES
    • 摩尔衍生物
    • WO1997000881A1
    • 1997-01-09
    • PCT/JP1996001730
    • 1996-06-21
    • NIPPON SHINYAKU CO., LTD.HASEGAWA, AkiraOHGI, TadaakiSETO, TakashiMORI, Kazuya
    • NIPPON SHINYAKU CO., LTD.
    • C07H17/02
    • C07H17/02
    • Moranoline derivatives represented by structural formula (I), wherein R represents lower alkyl substituted by acyl, alkoxycarbonyl, cyano, alkylcarbamoyl, nitro, acylamino, alkylthio, hydroxy or aryloxy, phenyl-lower alkyl wherein the benzene ring optionally has substituent(s) such as hydroxy, lower alkoxy, lower alkyl, halogeno, cyano, lower alkylcarbamoyl, nitro, acylamino, alkylthio or carboxy, lower alkyl substituted by a 5-membered unsaturated heterocycle optionally substituted by lower alkyl, alkenyl, arylalkenyl or higher alkyl; R and R are different from each other and each represents galactopyranosyl or fucopyranosyl substituted by hydroxysulfonyl or a metal salt thereof; and R represents hydroxy or acetamide. The compounds are useful in the medicinal field, for example, as an antiinflammatory agent or a preventive or remedy for ischemia and reflow disorders.
    • 烷氧基羰基,氰基,烷基氨基甲酰基,硝基,酰氨基,烷硫基,羟基或芳氧基,其中苯环任选具有取代基的苯基 - 低级烷基(其中R 1表示被酰基,烷氧基羰基,氰基, 羟基,低级烷氧基,低级烷基,卤代,氰基,低级烷基氨基甲酰基,硝基,酰氨基,烷硫基或羧基,被任选被低级烷基,烯基,芳基烯基或更高级烷基取代的5元不饱和杂环取代的低级烷基; R 2和R 3彼此不同,并且各自表示被羟基磺酰基或其金属盐取代的吡喃半乳糖基或糠醛吡喃糖基酯; R 4代表羟基或乙酰胺。 该化合物可用于药用领域,例如作为抗炎剂或用于缺血和回流障碍的预防或治疗。